FI952324A - Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet - Google Patents
Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet Download PDFInfo
- Publication number
- FI952324A FI952324A FI952324A FI952324A FI952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A
- Authority
- FI
- Finland
- Prior art keywords
- carbomate
- heterocyclic
- drugs
- preparation
- heterocyclic carbomate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4333761A DE4333761A1 (de) | 1993-10-04 | 1993-10-04 | Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel |
| PCT/EP1994/003280 WO1995009842A1 (en) | 1993-10-04 | 1994-10-04 | Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI952324A0 FI952324A0 (fi) | 1995-05-12 |
| FI952324A true FI952324A (fi) | 1995-05-12 |
Family
ID=6499349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI952324A FI952324A (fi) | 1993-10-04 | 1995-05-12 | Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5679677A (fi) |
| EP (1) | EP0649839A1 (fi) |
| JP (1) | JPH08504216A (fi) |
| AU (1) | AU684314B2 (fi) |
| CA (1) | CA2148361A1 (fi) |
| DE (2) | DE4345266C2 (fi) |
| FI (1) | FI952324A (fi) |
| NO (1) | NO952205D0 (fi) |
| WO (1) | WO1995009842A1 (fi) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407922B2 (en) * | 2005-10-13 | 2008-08-05 | S.C. Johnson & Son, Inc. | Deodorizing compositions |
| US7261742B2 (en) | 2005-10-13 | 2007-08-28 | S.C. Johnson & Son, Inc. | Method of deodorizing a textile |
| US8101624B2 (en) * | 2006-08-08 | 2012-01-24 | Aska Pharmaceutical Co., Ltd. | Quinazoline derivatives |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| WO2008091555A2 (en) | 2007-01-22 | 2008-07-31 | Gtx, Inc. | Nuclear receptor binding agents |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| DK2124562T3 (en) | 2007-03-09 | 2016-08-01 | Second Genome Inc | BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof |
| AU2011270701B2 (en) * | 2010-06-24 | 2015-05-14 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| EP2632466A4 (en) * | 2010-10-29 | 2014-03-19 | Univ Emory | QUINAZOLINE DERIVATIVES, COMPOSITIONS AND USES THEREOF |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CA2925944C (en) | 2013-10-04 | 2023-01-10 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| EP4066834A1 (en) | 2014-03-19 | 2022-10-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CN108349985A (zh) | 2015-09-14 | 2018-07-31 | 无限药品股份有限公司 | 异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法 |
| US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
| US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE36226B1 (en) * | 1935-11-11 | 1976-09-15 | Shimamoto Takio | Phthalazone derivatives |
| FR1460552A (fr) * | 1965-04-22 | 1966-03-04 | Agripat Sa | Additifs à des nourritures pour animaux |
| NL6702189A (fi) * | 1967-02-14 | 1968-08-15 | ||
| DE1807685A1 (de) * | 1968-11-08 | 1970-08-06 | Chinoin Gyogyszer Es Vegyeszet | Neue Chinazolon-Derivate und Verfahren zur Herstellung derselben |
| CH540266A (de) * | 1968-12-04 | 1973-08-15 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Chinazolon-Derivaten |
| JPS5418270B2 (fi) * | 1971-12-06 | 1979-07-06 | ||
| AR205004A1 (es) * | 1973-10-30 | 1976-03-31 | Ishikawa M | Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona |
| US4293553A (en) * | 1978-08-11 | 1981-10-06 | Masayuki Ishikawa | 1-Phthalazone derivatives, and use thereof |
| JPS5976069A (ja) * | 1982-10-25 | 1984-04-28 | Showa Denko Kk | フタラゾン誘導体 |
| GB2127805A (en) * | 1982-09-13 | 1984-04-18 | Showa Denko Kk | Phthalazones |
| US4769367A (en) * | 1984-04-24 | 1988-09-06 | Glaxo Group Limited | Heterocyclic amino compounds |
-
1993
- 1993-10-04 DE DE4345266A patent/DE4345266C2/de not_active Expired - Fee Related
- 1993-10-04 DE DE4333761A patent/DE4333761A1/de not_active Withdrawn
-
1994
- 1994-10-04 US US08/446,867 patent/US5679677A/en not_active Expired - Fee Related
- 1994-10-04 EP EP94115598A patent/EP0649839A1/en not_active Withdrawn
- 1994-10-04 WO PCT/EP1994/003280 patent/WO1995009842A1/en active Application Filing
- 1994-10-04 JP JP7510611A patent/JPH08504216A/ja active Pending
- 1994-10-04 CA CA002148361A patent/CA2148361A1/en not_active Abandoned
- 1994-10-04 AU AU77845/94A patent/AU684314B2/en not_active Ceased
-
1995
- 1995-05-12 FI FI952324A patent/FI952324A/fi unknown
- 1995-06-02 NO NO952205A patent/NO952205D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO952205L (no) | 1995-06-02 |
| DE4345266C2 (de) | 1996-12-19 |
| CA2148361A1 (en) | 1995-04-13 |
| NO952205D0 (no) | 1995-06-02 |
| JPH08504216A (ja) | 1996-05-07 |
| FI952324A0 (fi) | 1995-05-12 |
| DE4333761A1 (de) | 1995-04-06 |
| AU684314B2 (en) | 1997-12-11 |
| EP0649839A1 (en) | 1995-04-26 |
| DE4345266A1 (de) | 1995-06-29 |
| WO1995009842A1 (en) | 1995-04-13 |
| AU7784594A (en) | 1995-05-01 |
| US5679677A (en) | 1997-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI941137A0 (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
| FI953981A (fi) | 2-Bentsyyli-polysykliset guaniinijohdannaiset ja menetelmä niiden valmistamiseksi | |
| FI893542A0 (fi) | Entsyymielektrodit ja menetelmä niiden valmistamiseksi | |
| FI953479A (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
| FI952324A (fi) | Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet | |
| IS3720A7 (is) | Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun | |
| FI953898A (fi) | Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita | |
| BR9101250A (pt) | Metodo e aparelhagem de medicao de distancia | |
| FI962344A0 (fi) | Järjestelmä ja menetelmä selluloosan sisäänruiskuttamiseksi | |
| FI941777A0 (fi) | Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi | |
| FI954718A0 (fi) | Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi | |
| FI953967A0 (fi) | Laite ja menetelmä jauheen kostuttamiseksi | |
| FI962445A (fi) | Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi | |
| FI95914C (fi) | Polypeptidijohdannaisia ja menetelmä niiden valmistamiseksi | |
| FI944906A (fi) | Uudet sykliset aminohapot ja niiden johdannaiset | |
| FI964310A0 (fi) | Imidatsolijohdannainen ja menetelmä sen valmistamiseksi | |
| FI941914A0 (fi) | 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö | |
| FI944842A0 (fi) | Fluoratut 4-aminoandrostadienonijohdannaiset ja menetelmä niiden valmistamiseksi | |
| FI961977A0 (fi) | N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö | |
| FI940403A0 (fi) | Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi | |
| ATE202351T1 (de) | Pyridinderivate und sie enthaltende pharmazeutische zubereitungen | |
| FI964148A (fi) | Julkisivumateriaali ja menetelmä sen valmistamiseksi | |
| FI930378A0 (fi) | Fosfenoxidavslutade allen-en-yn dna-spjaelkande, antitumoer och antibiotika molekyler | |
| FI932768A (fi) | Farmaceutiska mjuka gelatinkapslar innehaollande lysinklonixinat och foerfarande foer framstaellning av dessa | |
| SE8901245D0 (sv) | Detekteringsfoerfarande och medel foer detta |